Skip to main content
NewslettersWatchlist

CooperSurgical® partners with Ostro to educate consumers about Paragard® (intrauterine copper contraceptive)

PR Newswire - Wed Dec 14, 2022

Technology partnership aims to increase engagement by educating consumers about CooperSurgical's Paragard

TRUMBULL, Conn., Dec. 14, 2022 /PRNewswire/ -- CooperSurgical, Inc., a leader in women's healthcare, and Ostro, a leading engagement platform dedicated to educating and empowering consumers and healthcare providers, today announced their partnership to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device that prevents pregnancy for up to 10 years.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).